Harvard Bioscience Current Ratio 2012-2026 | HBIO
Harvard Bioscience current ratio from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Harvard Bioscience Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2026-03-31 | $0.05B | $0.02B | 1.99 |
| 2025-12-31 | $0.05B | $0.02B | 2.20 |
| 2025-09-30 | $0.04B | $0.05B | 0.81 |
| 2025-06-30 | $0.05B | $0.06B | 0.82 |
| 2025-03-31 | $0.05B | $0.06B | 0.81 |
| 2024-12-31 | $0.05B | $0.06B | 0.82 |
| 2024-09-30 | $0.05B | $0.02B | 2.06 |
| 2024-06-30 | $0.05B | $0.02B | 2.05 |
| 2024-03-31 | $0.05B | $0.03B | 1.88 |
| 2023-12-31 | $0.05B | $0.03B | 1.85 |
| 2023-09-30 | $0.05B | $0.02B | 2.09 |
| 2023-06-30 | $0.05B | $0.02B | 2.29 |
| 2023-03-31 | $0.05B | $0.02B | 2.26 |
| 2022-12-31 | $0.05B | $0.02B | 2.20 |
| 2022-09-30 | $0.05B | $0.02B | 2.43 |
| 2022-06-30 | $0.06B | $0.02B | 2.42 |
| 2022-03-31 | $0.06B | $0.03B | 2.18 |
| 2021-12-31 | $0.06B | $0.03B | 2.43 |
| 2021-09-30 | $0.06B | $0.02B | 2.37 |
| 2021-06-30 | $0.05B | $0.02B | 2.30 |
| 2021-03-31 | $0.05B | $0.02B | 2.38 |
| 2020-12-31 | $0.05B | $0.02B | 2.46 |
| 2020-09-30 | $0.04B | $0.02B | 2.05 |
| 2020-06-30 | $0.04B | $0.02B | 1.95 |
| 2020-03-31 | $0.05B | $0.02B | 2.05 |
| 2019-12-31 | $0.05B | $0.03B | 2.12 |
| 2019-09-30 | $0.05B | $0.02B | 2.41 |
| 2019-06-30 | $0.05B | $0.02B | 2.52 |
| 2019-03-31 | $0.05B | $0.02B | 2.22 |
| 2018-12-31 | $0.06B | $0.03B | 2.27 |
| 2018-09-30 | $0.06B | $0.02B | 2.83 |
| 2018-06-30 | $0.05B | $0.02B | 2.42 |
| 2018-03-31 | $0.06B | $0.02B | 2.50 |
| 2017-12-31 | $0.05B | $0.01B | 3.39 |
| 2017-09-30 | $0.05B | $0.01B | 3.40 |
| 2017-06-30 | $0.05B | $0.01B | 3.46 |
| 2017-03-31 | $0.05B | $0.01B | 3.21 |
| 2016-12-31 | $0.05B | $0.02B | 3.11 |
| 2016-09-30 | $0.05B | $0.01B | 3.20 |
| 2016-06-30 | $0.05B | $0.02B | 3.15 |
| 2016-03-31 | $0.05B | $0.02B | 3.07 |
| 2015-12-31 | $0.05B | $0.02B | 2.62 |
| 2015-09-30 | $0.05B | $0.02B | 3.03 |
| 2015-06-30 | $0.06B | $0.02B | 2.66 |
| 2015-03-31 | $0.05B | $0.02B | 2.67 |
| 2014-12-31 | $0.06B | $0.02B | 3.15 |
| 2014-09-30 | $0.07B | $0.02B | 4.16 |
| 2014-06-30 | $0.06B | $0.02B | 3.94 |
| 2014-03-31 | $0.06B | $0.02B | 3.96 |
| 2013-12-31 | $0.06B | $0.02B | 3.78 |
| 2013-09-30 | $0.07B | $0.01B | 5.48 |
| 2013-06-30 | $0.07B | $0.01B | 5.47 |
| 2013-03-31 | $0.06B | $0.01B | 4.72 |
| 2012-12-31 | $0.06B | $0.01B | 5.96 |
| 2012-09-30 | $0.06B | $0.01B | 6.17 |
| 2012-06-30 | $0.06B | $0.01B | 5.88 |
| 2012-03-31 | $0.06B | $0.01B | 5.45 |
| 2011-12-31 | $0.06B | $0.01B | 6.02 |
| 2011-09-30 | $0.06B | $0.01B | 5.72 |
| 2011-06-30 | $0.06B | $0.01B | 6.08 |
| 2011-03-31 | $0.06B | $0.01B | 5.58 |
| 2010-12-31 | $0.06B | $0.01B | 5.19 |
| 2010-09-30 | $0.05B | $0.01B | 5.42 |
| 2010-06-30 | $0.05B | $0.01B | 4.63 |
| 2010-03-31 | $0.05B | $0.01B | 4.03 |
| 2009-12-31 | $0.05B | $0.01B | 3.93 |
| 2009-09-30 | $0.05B | $0.02B | 2.12 |
| 2009-06-30 | $0.04B | $0.01B | 4.80 |
| 2009-03-31 | $0.04B | $0.01B | 4.28 |
| 2008-12-31 | $0.04B | $0.01B | 3.88 |
| 2008-09-30 | $0.05B | $0.01B | 3.76 |
| 2008-06-30 | $0.05B | $0.02B | 3.28 |
| 2008-03-31 | $0.05B | $0.02B | 3.29 |
| 2007-12-31 | $0.05B | $0.02B | 3.32 |
| 2007-09-30 | $0.06B | $0.01B | 3.95 |
| 2007-06-30 | $0.05B | $0.01B | 3.69 |
| 2007-03-31 | $0.05B | $0.01B | 3.89 |
| 2006-12-31 | $0.05B | $0.02B | 3.63 |
| 2006-09-30 | $0.05B | $0.02B | 3.36 |
| 2006-06-30 | $0.06B | $0.02B | 2.98 |
| 2006-03-31 | $0.06B | $0.02B | 2.78 |
| 2005-12-31 | $0.06B | $0.01B | 4.23 |
| 2005-09-30 | $0.07B | $0.02B | 4.20 |
| 2005-06-30 | $0.05B | $0.02B | 3.13 |
| 2005-03-31 | $0.06B | $0.01B | 4.13 |
| 2004-12-31 | $0.06B | $0.02B | 3.82 |
| 2004-09-30 | $0.06B | $0.01B | 4.29 |
| 2004-06-30 | $0.06B | $0.01B | 3.95 |
| 2004-03-31 | $0.06B | $0.02B | 3.70 |
| 2003-12-31 | $0.06B | $0.02B | 3.58 |
| 2003-09-30 | $0.05B | $0.02B | 2.14 |
| 2003-06-30 | $0.05B | $0.02B | 2.11 |
| 2003-03-31 | $0.05B | $0.02B | 1.97 |
| 2002-12-31 | $0.05B | $0.02B | 2.92 |
| 2002-09-30 | $0.04B | $0.01B | 4.45 |
| 2002-06-30 | $0.05B | $0.01B | 4.93 |
| 2002-03-31 | $0.05B | $0.01B | 3.83 |
| 2001-12-31 | $0.05B | $0.01B | 3.68 |
| 2001-09-30 | $0.05B | $0.01B | 5.81 |
| 2001-06-30 | $0.05B | $0.01B | 5.52 |
| 2001-03-31 | $0.05B | $0.01B | 11.53 |
| 2000-12-31 | $0.05B | $0.01B | 7.37 |
| 2000-09-30 | $0.01B | $0.01B | 1.10 |
| 2000-06-30 | $0.00B | 0.00 | |
| 2000-03-31 | $0.00B | 0.00 | |
| 1999-12-31 | $0.01B | $0.01B | 1.50 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |